MedPath

A biomarker study of soluble immune markers in stage II-IIIA non-small cell lung cancer (WJOG12319LTR)

Not Applicable
Conditions
Resectable stage II-IIIA non-small cell lung cancer
Registration Number
JPRN-UMIN000037723
Lead Sponsor
West Japan Oncology Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
152
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath